Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales at its medical products business continued to grow. Net adjusted income rose to $741 million, or $1.35 per share, in the third quarter ended Sept. 30, from $681 million, or $1.24 per share, a year earlier.Net sales grew 13 percent to $4.2 billion.Analysts on average had expected earnings of $1.31 per share, excluding items, on revenue of $4.2 billion, according to Thomson Reuters I/B/E/S.Sales at the company's medical products business - which includes intravenous fluid systems, dialysis, biosurgery and some specialty pharmaceuticals such as anesthesia and nutrition - were up 17 percent to $2.5 billion in the third quarter.
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Shares of BAX fell by 0.76% or $-0.52/share to $68.34. In the past year, the shares have traded as low as $64.78 and as high as $77.31. On average, 2234610 shares of BAX exchange hands on a given day and today's volume is recorded at 4599369.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.28% or $0.1/share to $35.77. In the past year, the shares have traded as low as $33.21 and as high as $38.73. On average, 718540 shares of TRI exchange hands on a given day and today's volume is recorded at 1980363.
Thomson Reuters Corporation (Thomson Reuters) is a provider of information for the world?s businesses and professionals. Shares of TRI fell by 0.2% or $-0.08/share to $40.22. In the past year, the shares have traded as low as $35.59 and as high as $42.10. On average, 699876 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 1193239.
Source